Trump, RFK Jr. launches a $500 million universal vaccine initiative
Dr. Marc Siegel, senior medical analyst at Fox News, discusses the Trump administration’s initiative to develop vaccines targeting multiple viruses, and the Murdoch Children’s Research Institute is studying linking potential vaccines.
Elderly people are warned against receiving Chikungunya vaccine Before you travel.
The Ixchiq vaccination developed by Barneva to prevent mosquito-borne chikungunya virus was approved in November 2023 by the Food and Drug Administration (FDA) as the first of its kind.
Approval applies to people over the age of 18 at risk of exposure to the virus.
The first vaccine for Chikungunia virus, a “new global health threat,” has been approved by the FDA.
However, the FDA and the Centers for Disease Control and Prevention (CDC) issued a safety notice on May 9th, recommencing it. Adults over 60 Suspends vaccine use due to fatal complications.
“FDA and CDC will continue to evaluate IXCHIQ’s post-market safety reports,” the release reads.
Elderly people have been warned against receiving the Chikungunya vaccine before their trip. (istock)
“While the safety of IXCHIQ for use in individuals over 60 has been further evaluated, the FDA and CDC recommend suspending vaccine use in this age group. The FDA and CDC will update the public once they complete their assessment of this safety issue.”
Advisory follows reports of neurological “serious adverse events.” Heart Events People who received the vaccine.
Click here to get the Fox News app
Two of the 17 events resulted in death from severe complications. One death was caused by encephalitis Brain inflammationthe alert said.
People who have experienced the adverse effects of the vaccine were reported to be between the ages of 62 and 89.
A patient infected with Chikunguña looked out of a mosquito net at Clinicus Hospital in San Lorenzo, Paraguay in March 2023. The FDA warned that ixchiq, which includes a weakened version of the virus, could cause similar symptoms against Chikungunya. (AP Photo/Jorge Saëns)
The FDA includes a weakened version of Chikungunya live, and Ixchiq is virus.
According to the CDC, typical symptoms of Chikungunya include fever, severe joint pain, headache, muscle pain and rash.
Click here to sign up for our health newsletter
While most people recover within a week, some may experience “severe and disability” joint pain for weeks or months.
Chikungunya is spread by the bite of an infected mosquito. (istock)
“This virus is in a similar category to dengue fever and Zika; Same mosquito“Dr. Marc Siegel, senior medical analyst at Fox News, previously told Fox News Digital.
At the time of vaccine approval, the FDA described Chikungunya as “emerging global.” The threat of health“At least 5 million cases have been reported over the past 15 years.
Visit us for more health articles www.foxnews.com/health
The FDA plans to conduct an “updated profit risk assessment” for use of Ixchiq in people over the age of 60, according to the notification.
Melissa Rudy of Fox News Digital contributed to this report.
